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In the interest of improving patient outcomes, significant investments in operationalized 
quality of care within the Medicare space have promulgated a low-resolution narrative 
predicated on conflation of higher quality scores with improved population health. 
Concomitant financial incentivization of Medicare Advantage plans through aligned Star 
Measures places contracts as the fundamental unit of most care quality analyses, but no 
studies have considered how present incentivization schema have impacted physician use 
and associated quality scores over time for breast cancer screening (BCS), colorectal 
cancer screening (CCS), and annual flu vaccination (AFV) at a county level. Guided by 
the Evidence Based Model framework, this quantitative cross-sectional secondary data 
study used simple linear regression, Spearman Correlation, and Mann Kendall Trend tests 
to analyze public Medicare quality and physician claims data. Results showed that AFV 
utilization correlated with aligned quality scores for U.S. counties between 2012 and 
2017, but no such association was found to exist for CCS or BCS. County-level physician 
use slightly increased over this period for BCS and AFV, but a small monotonic decline 
was observed for CCS. Year-over-year changes in quality scores did not correlate with 
changes in physician use of each preventive service. Study findings indicated that 
incentivized quality measures aimed at health plan performance are insufficient to 
produce measurable population-level impacts in the utilization of preventive services in 
the Medicare space. This study contributes to positive social change by highlighting that 
health plans can demonstrate improvements in incentivized quality measure performance 
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Chapter 1: Introduction to the Study 
 Amid continual increases to Medicare spending allocations in the United States, 
efforts have been underway to improve efficiency of care and establish best practices that 
maximize cost-effective health management for the older U.S. population. Following 
formalized considerations of 50 definitions and 50 parameter sets spanning 24 delineated 
dimensions, the Institute of Medicine defined quality health care in 1990 as: “the degree 
to which health services for individuals and populations increase the likelihood of desired 
health outcomes and are consistent with current professional knowledge” (Lohr & 
Schroeder, 1990, p. 707). In the 3 decades that followed, multiple instantiations of this 
conceptual framework have been developed, including various iterations of health 
information technology (HIT; Halamka & Micky, 2017) and defined quality measures 
published by organizations such as the National Committee for Quality Assurance 
(NCQA; Richter & Beauvais, 2018) and the Centers for Medicare and Medicaid Services 
(CMS; Schroeder, 2019; Sung-Heui Bae, 2017). By way of such measures, efforts to 
improve population health have been defined and subsequently enacted by health care 
administrators overseeing the standardization of medical care. 
 To engender adherence to recommendations, quality measures are typically 
incentivized through bonus payments, penalties, and withholds flowing from payers 
down through provider networks to individual physicians (Eckhardt, Smith, & Quentin, 
2019). The concomitant, low-resolution narrative of quality measures improving health 
care rests upon three fundamental assumptions, the first of which posits that operational 




care processes and outcomes within the control of health care professionals (HCPs) and 
health care organizations. The second assumption is that receiving higher scores on 
health care quality measures will always translate into better outcomes and lower overall 
costs. Finally, the health care quality framework assumes that incentivizing HCP 
behaviors to align with prescribed best-practices, allegedly built upon empirical data, will 
result in positive population-level effects.  
 In practice, this approach of rewarding care quality instead of quantity has given 
rise to over 2,500 incentivized measurements, most of which have not resulted in the 
intended improvements to patient outcomes, care efficiencies, or aggregate cost-savings 
(Eijkenaar, Emmert, Scheppach, & Schöffski, 2013; Mendelson, et al., 2017). Valuck, 
Sampsel, Sloan, and Van Meter (2019) point out the additional difficulty of keeping 
operationalized quality up to date with evolving understanding, resulting in discrepancies 
between definitions of quality and optimal patient care. The accelerating proliferation of 
HIT-enabled, top-down control of medical standards by administrators incentivizing 
prescribed quality measures makes it more important than ever to evaluate population 
impacts. 
Problem Statement 
Policymakers for the U.S. healthcare system are presently testing whether 
administrator-led standardizations of care will result in both improved health outcomes 
and lower costs. However, the framework being used to incentivize adoption of 
predefined quality care metrics remains generally unproven in the healthcare field 




mixed: According to a Congressional Budget Office report, several “financial incentives” 
used “to encourage providers to follow” standards of care have been inconsequential to 
patient outcomes and may even potentially distract physicians from other processes 
(Hayford & Maeda, 2017, p. 2). A systematic review by Houle, McAlister, Jackevicius, 
Chuck, and Tsuyuki (2012) showed that physician pay-for-performance efforts may even 
enrich doctors without meaningfully impacting patient care at all. Extrinsic awards have 
corralled physician behavior even when prescribed measures have lacked empirical 
support (Herzer & Pronovost, 2015; Sobieski, 2016). 
Within the United States, quality schemes such as NCQA’s Health Plan Employer 
Data and Information Set (HEDIS) and CMS Star Ratings largely operationalize quality 
preventive health care in terms of defined optimal processes. Higher-scoring institutions 
receive more money and membership enrollment privileges, presumably for delivering 
better care, despite the persistence of population-level predictors suggesting that health 
systems are being largely awarded for factors beyond their control (Hu, Schreiber, 
Jordan, George, & Nerenz, 2017). While the literature is rife with granular examples of 
quality-improvement programs working in special cases, few studies have considered the 
aggregate impact of incentivizing quality scores standardizing utilization of preventive 
health services. This research confronted the problem of incentivizing preventive care 
regimens in the absence of proven aggregate impact. My study attempted to solve that 
problem by considering how more than a decade of preventive care incentivization has 
impacted annual flu vaccination (AFV), breast cancer screening (BCS), and colorectal 




also considered whether aligned quality scores representing appropriate preventive health 
care reflected changes in the aggregate utilization of these preventive care regimens at the 
county level from 2012 to 2017. 
Purpose of the Study 
The purpose of this quantitative study was to examine the impact of incentivized 
preventive care quality measures on physician use of preventive care at the population-
level. Current financial incentives are tied to process measures defined by payer and 
health system administrators, and this research considered how these have impacted 
alignment to important public health processes. To estimate the effects of aligned 
physician behavior, a quantitative analysis was conducted on archived data from CMS. 
Specifically, I compared longitudinal utilization of incentivized preventive care including 
colonoscopies, mammograms, and influenza immunizations and evaluated these trends 
against county-aggregated performance on aligned quality measures. I looked at whether 
incentivizing quality measures have impacted longitudinal use of these preventive 
measures across the U.S. Medicare population at the health plan-agnostic, county level of 
analysis.  
Nature of the Study 
 This research employed a quantitative design and considered established 
preventive care quality metrics using secondary analysis of archived data. My approach 
explored three iterations of a fundamental question: To what extent has incentivizing 
recommended preventive care practices, codified in current quality metrics, driven 




investigation into 3 research questions (RQs). After confirming the association between 
pooled physician use of preventive services and aggregated quality scores (RQ1), I 
assessed retrospective longitudinal differences (RQ2). Next, I looked at whether any 
detected differences in physician utilization of incentivized preventive care correlated to 
changes in aligned quality score distributions (RQ3) from 2012 to 2017 at a county-
aggregated level across the United States.  
Research Questions and Hypotheses 
RQ1: Were there county-level differences in physician utilization of preventive 
services that correlated to associated quality score distributions from 2012 to 2017?  
H01: County-level physician utilization of preventive services were not correlated 
with associated quality measure score distributions. 
Ha1: County-level physician utilization of preventive services were correlated 
with associated quality measure scores.  
RQ2: Has Medicare physician utilization of colonoscopies, mammograms, and 
influenza immunizations changed at the county level from 2012 to 2017?  
H02: Medicare physician utilization of colonoscopies, mammograms, and 
immunizations have not changed at the county level. 
Ha2: Medicare physician utilization of colonoscopies, mammograms, and 
immunizations have changed at the county level. 
RQ3: Were there observed correlations between changes in physician utilization 





H03: Changes in physician utilization of preventive care at the county-level did 
not correlate with associated quality measure score distributions. 
Ha3: Observed associations in physician utilization of preventive care at the 
county-level correlated with associated quality measure score distributions. 
Theoretical Framework 
 The Evidence Based Model (EBM) framework informed this longitudinal study. 
Masic, Miokovic, and Muhamedagic (2008) defined EBM as “the conscientious, explicit, 
judicious and reasonable use of modern, best evidence in making decisions about the care 
of individual patients” (p. 219). In practice, such efforts are predicated upon standardized 
processes of care that maximize efficiency, decrease health care costs, and optimize 
outcomes. Given the emphasis on U.S. quality care incentivization, the behavioral 
economic model discussed by Matjasko, Cawley, Baker-Goering, and Yokum (2016) was 
used to contextualize EBM applications within the present health care quality narrative.  
 My research considered how incorporation of incentives, establishment of norms, 
and HIT-driven default standards of care have impacted physician utilization of 
preventive services and associated CMS quality measures. The efficacy and reliability of 
EBM-based guidelines can vary, so I incorporated Mosadeghrad’s (2012) pluralistic 
approach to defining quality care to address potential incongruencies in the 
operationalization of quality healthcare. Since quality scores built on an EBM model 
serve as a proxy for delivery of quality health care, this approach provided a means by 
which aggregate population-level health trends could be considered in the context of the 




Operational Definitions of Variables 
• Preventive care: proactive medical procedures undertaken to decrease the 
prevalence of preventable disease or identify illnesses in their early stages to 
improve prognosis and outcomes at lower costs, including: 
o Influenza immunizations 
o Cancer screening 
▪ Colonoscopies 
▪ Mammograms 
• Quality measures: operationalized proxies for desired patient outcomes, 
including conformance to processes expected to yield measurable 
improvements in health outcomes, efficiencies in care, and overall cost-
savings (CMS 2019). 
o Percentage of plan members who received a flu shot in year of 
measure 
o Percentage of plan membership between 50 and 75 years of age 
who received appropriate colon cancer screen 
o Percentage of female plan membership between 52 and 74 years of 
age who received a mammogram in last 2 years 
Limitations 
For this study, a few methodological limitations were identified. First, data 
describing Medicare preventive service utilization came from two Medicare segments, 




Advantage quality scores. Potential differences in cancer screening and influenza 
immunization practices between FFS and Medicare Advantage populations may exist. 
Additionally, the lack of published data demonstrating population-level impact of 
incentivized preventive care makes it difficult to anticipate potential confounders to 
observable effects. Finally, factors such as care system fragmentation, differing market 
pressures in highly capitated areas, varying distributions of HIT-driven integrated 
delivery networks, and socioecological variables not considered in this study may impact 
both the use and effects of preventive care across the broader U.S. Medicare population. 
Future research might consider other variables that potentially impact subpopulations. 
Another limitation of this study was the method by which physicians were 
associated with counties. The CMS public use file I used specified the National Plan and 
Provider Enumeration System (NPPES) zip code in which the physician was registered 
for each year, and that was used to group physicians into county aggregates. Physicians 
often practice in several zip codes, and this was not indicated in the public use file, with 
the greatest potential distortions identified in rural areas such as Alaska. Physicians 
moving from one state to another could also have accounted for some of the county-
specific variations in billed preventive services from 2012 to 2017, but this was not 
considered in the context of my longitudinal analysis. 
Scope and Delimitations 
For the purposes of this study, I used secondary data describing medical care 
provided to Medicare beneficiaries and aligned preventive care quality measure scores. 




services beyond influenza immunizations, colonoscopies, and mammograms were not 
considered. Available aggregate health expenditure data on AFV, CCS, and BCS do not 
discern between possible differences in patient risk groups and access to preventive care 
in general over the considered period.  
The Significance of the Study 
 This research filled a gap in understanding how incentivized preventive health 
quality measures have impacted physician-level activity and associated population-level 
quality measures across the U.S. Medicare population at the county level. It was unique 
in its consideration of whether current narratives guiding definitions of “quality care in 
medical practice” have led to the adoption of a provider incentivization scheme that has 
meaningfully contributed to public health practice, particularly with respect to the use of 
incentivized preventive measures inconsistently supported by the literature. The results of 
this study clarified for public policy experts the extent to which data currently support 
U.S. preventive health care quality narratives and their alignment with present physician 
incentivization. Findings also demonstrated whether the use of extrinsic motivators to 
elicit conformance with administrator-led initiatives, intended to improve the efficiency 
and outputs of care, were associated with aligned, county-level quality measure 
performance across the United States. 
Social Change Contribution 
Findings contributed to positive social change by clarifying the relationship 
between incentivized quality score measures and their aggregate effect on preventive 




alignment of financial incentivization with measures that meaningfully contribute to 
improvements in population health. Despite persisting narratives around the value of 
preventive care, the literature is sparse in demonstrated associations between preventive 
care utilization trends and their relationship to population-level quality measure 
performance. This study tested for observable associations between incentivization of 
quality scores and population-level changes in the utilization of preventive care services 
aimed at improving public health. 
My study also helped fill a literature gap as to whether Medicare’s preventive care 
quality framework is detectably associated with county-level improvements in utilization 
of preventive services aimed at lowering costs and improving population outcomes. 
Clarifying the relationship between physician utilization of incentivized preventive care 
and affiliated quality measure scores is critical to knowing whether the current approach 
is working. Testing for statistical significance at the aggregated county level helped me 
assess the assumed success of current quality programs intended to advance 
incentivization of processes that drive observable improvements to population health. 
Summary and Transition 
To improve access and utilization of effective health care, organizations such as 
CMS have incentivized several aligned quality measures. A low-resolution narrative has 
emerged supporting top-down administrative control of medicine in accordance with 
these quality standards, including preventive care regimens intended to improve patient 
outcomes, increase efficiencies in medical care, and decrease medical costs. Defining 




how evolving definitions have impacted physician use of preventive care in the Medicare 




Chapter 2: Literature Review 
A thorough literature review was conducted to place this study into context with 
respect to the evolution of health care quality operationalization, emphasizing preventive 
care measures and associated incentivization of idealized care processes. In the first 
subsection of this literature review, I explore historical definitions of health care quality 
leading to the establishment of preventive care standards. Then, I look at preventive care 
utilization, followed by a summary of limited data on population-level impact trends. In 
the third subsection, I consider disparities in the utilization of recommended preventive 
care in the Medicare population. Each section summarizes issues pertinent to my study 
variables and methodology, along with the existing literature gap on whether CMS Star 
Measures relating to immunizations, colorectal screening, and mammograms in the 
Medicare population are associated with detectable impacts in physician utilization or 
longitudinal improvements to population health. This chapter concludes with a synopsis 
of the literature gap that I attempted to fill with this study. 
Literature Sources and Search Criteria 
 Using the Walden University Library, I accessed several search engines and 
databases to locate seminal literature and peer-reviewed research published after 2016. 
These included Science Direct, PubMed, Sage Publications, Google Scholar, Academic 
Premier, Academic Search Complete, and CINAHL. I used several combinations of 
keywords including health care quality, preventive care, provider incentivization, 
outcomes, return on investment, impact modeling, immunizations, colorectal screening, 





Defining Quality Preventive Care 
Preventive care has long been lauded as a prophylactic supporting population 
health, a way to maximize human thriving and minimize costs of medical care by 
constraining nascent rates of chronic and vaccine-preventable diseases (Levine, Malone, 
Lekiachvili, & Briss, 2019). To assist with the establishment of preventive care standards 
within the Medicare population, a subset of these services has been standardized and 
recommended for routine use in the older adult population by the U.S. Preventive 
Services Task Force. According to the United States’ Agency for Healthcare Research 
and Quality (AHRQ; 2020), this task force was formed by a Congressional mandate in 
1984 to serve as an independent expert panel informing recommendations of preventive 
care services. These recommendations are formulated by empirical data supplemented by 
expert opinion and have not always considered cost-effectiveness or transparent process 
(Saha et al., 2001). Complicating factors such as false positives in cancer screenings and 
variations in utilization (Narayan, Elkin, Lehman, & Morris, 2018) make it difficult to 
advance single standards of preventive care, a situation exacerbated by racial and ethnic 
disparities in utilization (Gray et al., 2017; Jack, 2018). 
Multiple organizations have risen to the challenge of operationalizing quality 
healthcare in the preventive care space, such as the NCQA, a consultancy whose 
collaborations with industry stakeholders led to the creation of HEDIS (McIntyre, 
Rogers, & Heier, 2001). The NCQA, a non-profit organization incorporated in 1990, 




of audits, earned accreditations, and various other quality score-related manuals and 
services, suggesting significant marketplace interest in improving measuring and targeted 
interventions that address preventable negative patient outcomes. According to NCQA 
(2020), “health care was operating data-free and ‘in the dark’” before they formed their 
organization to sell measurements and improvements to “turn on the lights” (p. 1). 
Whether or not this is marketing hyperbole, grants and contracts with various health plans 
and governmental agencies have positioned NCQA as an authority in the quality domain; 
CMS contracted with NCQA to develop quality measures by which the performance of 
health plans managing its special needs populations could be benchmarked and 
incentivized sufficiently to drive performance (CMS, 2020; NCQA, 2020).  
CMS (2019) also developed its own set of measurements called the Star Rating 
System, a set of defined processes and outcomes operationalizing standards for quality 
healthcare for Medicare Advantage plans. According to CMS, plans are assessed between 
1 and 5 Stars for several measures across multiple domains, with higher scores earning 
plans quality bonus payments and increased opportunities to enroll new beneficiaries into 
their Part C and Part D plans. Average health plan Star Ratings on each of these measures 
have varied by year, and preventive care incentivized through these measures included 
recommended cancer screenings and annual flu vaccine as follows: 
Table 1 
 




















      
C01 Breast cancer screening 4.1 3.1 3.4 3.5 
      
C02 Colorectal cancer 
screening 
3.2 3.4 3.8 3.8 
      
C03 Annual flu vaccine 3.3 3.2 3.2 3.2 
      
 
From “2020 Star Ratings Fact Sheet,” by Centers for Medicare and Medicaid Services, 
2020 (https://www.cms.gov/Medicare/Prescription-Drug-
Coverage/PrescriptionDrugCovGenIn/PerformanceData). 
Consistent reporting of these preventive measures highlights unequal utilization 
across various sociodemographic groups. Several studies emphasize lower immunization 
rates in Hispanic and African American communities (Hughes, Saiyed, & Chen, 2018; 
Nowalk, et al., 2019). Other research documents associations between socioecological 
variables, generally referred to as social determinants of health, and varying utilization of 
preventive health services (Hughes, Baker, Kim, and Valdes, 2019). Kim, Charlesworth, 
McConnell, Valentine, and Grabowski (2019) provide additional context around the need 
for special management of dual-eligible low-income subsidy (DE-LIS) populations, in 
line with CMS quality score corrections provided to health plans managing risk for 
patients simultaneously eligible for both Medicare and Medicaid benefits. Overall, the 
academic literature on quality measure performance focused on predictors of disparities 
in measure adherence and outcomes, qualitative reporting of experiences with quality 





Preventive Care Utilization 
 Multiple efforts to improve utilization of preventive care were identified. Payers 
and providers have been increasingly incentivized to utilize general preventive care 
services despite inconsistent empirical corroboration for pay-for-performance programs 
(Ammi & Fortier, 2017; Frakt & Jha, 2018; Roberts, Zaslavsky, & McWilliams, 2018). 
Provisions in the Affordable Care Act (ACA) eliminated patient financial barriers by 
providing access in the form of first-dollar coverage for recommended preventive care 
services such as influenza and pneumococcal immunizations, wellness visits, and cancer 
screenings (Misra, Lloyd, Strawbridge, & Wensky, 2018; Xu, Wickizer, & Jung, 2019). 
Alharbi, Khan, Horner, Brandt, and Chapman (2019) found that eliminating cost-sharing 
did not impact use of some preventive care measures, such as mammograms and pap 
tests. However, comparison of pre- and post-ACA utilization of Medicare wellness visits 
showed significant increases in utilization, from 1.4% in 2005 to 12.3% in 2016 (Misra, 
Lloyd, Strawbridge, & Wensky, 2018). Overall, the data have been inconsistent, 
potentially confounded by geographic differences spanning Medicare, Medicaid, DE-LIS, 
and commercial insurance strata.  
 Such confounding has made it difficult to assess whether elimination of cost-
sharing or physician incentivization has impacted preventive care use. For example, 
Misra, Lloyd, Strawbridge, and Wensky (2018) found that the post-ACA rate of Annual 
Wellness Visits (AWVs) were lower in non-Whites, men, beneficiaries lacking 
supplemental insurance, and geographies outside of the Northeast. Research by Chung, 




Medicare FFS compared to Medicare Advantage (i.e., health plan-managed) populations, 
as well as among cohorts of older or comorbid beneficiaries following the removal of 
cost-sharing. Lack of positive impact from billable preventive services can further 
complicate these assessments, such as Simpson and Kovich’s (2019) conclusion that very 
limited evidence has been published supporting beliefs that AWVs will improve 
longevity in the older adult population. 
Evidence of Population Impact Trends 
 Overall, very little evidence has been published on implemented, cost-effective 
preventive care standards in both general and vulnerable populations. One suggested 
contributor to this gap separating preventive care narrative from realized impacts is slow 
payer adoption of incentive schemes aligned with long-term population health benefit 
(Pryor & Volpp, 2018). Wilson et al. (2018) suggested that confirmation and publication 
biases may reflect a preventive care phenomenology reinforcing the criticality of 
democratized access to healthcare and equal utilization of preventive services despite 
lack of supporting longitudinal population-level studies. Other researchers have focused 
on alignment of care quality measures, expressing concern about ambiguities or 
inconsistencies in underlying methodologies applied to diverse populations (Bilimoria & 
Barnard, 2016; Frakt & Jha, 2018; Roberts, Zaslavsky, & McWilliams, 2018). Pryor and 
Volpp (2018) observed payer prioritization of palliative care with demonstrated short-
term ROIs contributing to under- or mis-incentivization of preventive services. HCP 




benchmarking and factors impacting low patient adherence were also suggested as 
barriers to preventive care uptake. 
 The literature also distinguished between access to preventive care and its 
utilization, such that the two were readily distinguishable within some populations. In the 
pre-ACA era, Benjamins, Kirby, and Bond Huie (2004) found that the ethnic composition 
of the county partially predicted preventive care use. This finding has remained 
consistent despite elimination of cost-sharing and persisting incentivization schemes 
associated with quality improvement frameworks. For example, multiple studies report 
sociodemographic and community-level predictors of preventive care including Medicare 
AWVs (Hohmann, Hastings, Quin, Curran, & Westrick, 2019), cancer screenings (Moss 
et al., 2019), and receipt of recommended immunizations (Shen et al., 2019). These 
findings suggest that factors beyond both payer health system control may predict 
aggregate health care quality scores.  
 Other studies highlight questionable associations between standardized care 
practices designed to impact quality metrics and actual impacts in a targeted Medicare 
population. Leung, Beadles, Romaire, and Gulledge (2019) found that a Medicare 
primary care practice demonstration defining preventive care process quality measures 
failed to demonstrate intended population improvements and increased avoidable 
hospitalizations in some cohorts. After five years of a direct pneumococcal immunization 
program launched for the 65 and older Medicare population, at a cost of billions of 
taxpayer dollars, little to no statistically significant impact was observed by the CDC 




to prescribed actions within a best-practice paradigm, can include standardized 
preventive care practices without demonstrated population-level impact. 
Disparities in Incentivized Preventive Care Uptake 
 Complexities in health care require coordination among provider groups including 
specialists, nurses, general practitioners, hospitalists, and other care management 
professionals. One difficulty in assessing the external validity of quality schema is the 
reduction of multifactorial complexities into single, measurable events such as 
vaccination or cancer screenings tied to differences in patient outcomes. Work on social 
determinants of health, for example, implicates population-level factors in 
rehospitalization, adherence to prescribed treatment, and health plan quality scoring on 
myriad measures that may be better predicted by local socioecological and demographic 
variables than by anything over which a health care facility has control. McCalman, 
Bainbridge, and Bailie (2019) found that less than 20% of health outcome improvements 
are due to healthcare services themselves and that sociocultural variables had a greater 
effect on patient outcomes.  
 Some research focused on disproportionate negative impacts of poorer 
populations on quality score performance, contributing additional confounding effects on 
comparisons between diverse geographies. Toseef, Jensen, and Terraf (2019) found 
higher preventable hospitalizations in Medicaid managed care segments than in FFS 
Medicaid counterparts. An examination of long-term care patient outcomes showed 
worse outcomes for non-White racial/ethnic groups (Gorges, Sanghavi, & Konetzka, 




disparities impacting racial/ethnic minorities may differently impact health plan 
performance on quality measures. For this reason, CMS has been working with several 
states to enhance care coordination between Medicare and Medicaid to better manage 
these populations, a task made more difficult by complex coverage and data availability 
challenges (Kim, Charlesworth, McConnell, Valentine, & Grabowski, 2019). No studies 
were found associating interventions addressing these inequalities with population-level 
impact. 
 Within the preventive care domain, Shen et al. (2018) noted persistent lower 
influenza immunization rates among Medicare FFS Hispanic and Black populations 
compared to White and Asian cohorts, as well as lower overall vaccination rates of DE-
LIS segments. Berland et al. (2019) found higher cancer mortality and barriers to cancer 
screening negatively impacting racial/ethnic minority groups and lower socioeconomic 
populations. For example, disparities observed in colon cancer screening trends may have 
been worsened due to high coinsurance costs associated with extended testing and polyp 
removal (Florea, Brown, Harris, & Oren, 2019; Montminy, Karlitz, & Landreneau, 
2019). The reasons for overall disparities are multifactorial, including low reading levels 
among poor and uneducated older adults whose low health literacy is likely to negatively 
impact health outcomes (DeWalt, Berkman, Sheridan, Lohr, & Pignone, 2004; Marshall 
& Hale, 2019).  
Summary and Conclusions 
The literature indicated that effective preventive care can be expected to increase 




operationalized this care within an EBM framework, adopting metrics to serve as proxies 
for quality preventive care with varying degrees of evidence and success. In the Medicare 
space, CMS incentivizes utilization of defined preventive care such as influenza 
immunizations and cancer screenings. Disparities have been found in their utilization, 
with lower-socioeconomic populations less likely to receive recommended care, and this 
has received significantly more attention than overall population-level impacts associated 
with the uptake of such measures.  
No studies were found associating population-level interventions addressing these 
inequalities with meaningful changes to either aggregate quality scores or preventive care 
utilization. No data were found in the literature associating longitudinal improvements in 
preventive care quality scores with population outcomes. Finally, no quantitative studies 
were found indicating that increased use of preventive care resulting from provider 
incentivization improved any population health outcomes in aggregate. My study helped 
to begin filling these gaps by testing whether changes in physician use of preventive 
services were associated with aligned health care quality measures in the Medicare space 




Chapter 3: Research Method 
In this section I provide the research methods used in my study to assess 
longitudinal trends in quality measure performance and preventive care use in the U.S. 
Medicare population through analysis of secondary data. Using a cross-sectional design, I 
looked at whether incentivization of preventive care resulted in any aggregate changes to 
their use within the Medicare FFS space at the population level using county 
aggregations. I also examined whether any longitudinal changes in such utilization are 
associated with scores on aligned, incentivized quality measures. 
Research Questions and Hypotheses 
RQ1: Were there county-level differences in physician utilization of preventive 
services that correlated to associated quality score distributions from 2012 to 2017?  
H01: County-level physician utilization of preventive services were not correlated 
with associated quality measure score distributions. 
Ha1: County-level physician utilization of preventive services were correlated 
with associated quality measure scores.  
RQ2: Has Medicare physician utilization of colonoscopies, mammograms, and 
influenza immunizations changed at the county level from 2012 to 2017?  
H02: Medicare physician utilization of colonoscopies, mammograms, and 
immunizations have not changed at the county level. 
Ha2: Medicare physician utilization of colonoscopies, mammograms, and 




RQ3: Were there observed correlations between changes in physician utilization 
of preventive services and associated county-level quality score distributions from 2012 
to 2017? 
H03: Changes in physician utilization of preventive care at the county-level did 
not correlate with associated quality measure score distributions. 
Ha3: Observed associations in physician utilization of preventive care at the 
county-level correlated with associated quality measure score distributions. 
Design of the Study 
Through a secondary analysis of archived data, I designed my research to clarify 
the extent to which modern emphasis on selected preventive health measures within the 
Medicare population changed physician utilization and aligned quality measure scores. 
Quantitative analyses were selected to separately test for these associations, such that 
both the extent and nature of each association could be readily understood. This study 
design helped me support a novel application of public CMS data by splitting the extant 
preventive health narrative into component research questions directed at understanding 
trends at a geographically aggregated level of preventive health regimen utilization 
intended to positively impact population health. 
Sampling 
My research included all physician billing for medical services provided to the 
annual Medicare FFS population of the United States between 2012 and 2017. Quality 
scores associated with cancer screening and immunizations reflected the performance of 




on the associated measures and had a plan membership over 10 people, below which 
CMS blinds county-level data.  
Data Sources and Variables 
The secondary data utilized in this study came from downloadable, public use 
files published by CMS. Physician-level data from 2012 to 2017 on billed preventive care 
medical procedures is provided by CMS for all U.S. physicians billing Medicare directly 
for services and is accessible through Physician/Supplier Procedure Summaries built 
from complete claims data representing medical expenditures for the entire U.S. 
Medicare FFS population by year. Distinct Healthcare Common Procedure Coding 
System (HCPCS) codes delineate immunizations, colonoscopies, and mammograms 
within these files, aggregated to individual physicians at the zip code level. These zip-
level data were mapped to corresponding county aggregates using United States Postal 
Service maps derived by way of a zip info crosswalk.  
I downloaded Star Measure Quality data from CMS, which provided me with 
health plan performance scores on influenza immunization, colonoscopies, and 
mammograms. Scores pulled from this source represent Medicare Advantage health plans 
potentially operating across multiple counties, so a complementing CMS data set was 
pulled for each year to distribute memberships of reporting health plans across each 
included county. In this way, weighted averages of measure scores can be ascertained at a 
county level, reflecting a composite of multiple plans’ performance on each. CMS 




established operationalization of quality preventive care activities such as influenza 
immunizations, colonoscopies, and mammograms.  
Data Analysis 
My study tested for longitudinal changes at an aggregated county level in 
physician-level utilization of influenza immunization, colonoscopies, and mammograms, 
and whether these trends correlated with changes in associated quality scores. The public 
use CMS data file I used to determine county-level billed influenza immunizations, 
colonoscopies, and mammograms included all services provided to Medicare FFS 
beneficiaries and submitted for payment by HCPs across the United States. As such, it 
represented the entire sample of the FFS population considered in this analysis. Similarly, 
the annualized CMS Quality Score data that I used contains all Medicare Advantage 
plans reporting performance on included measures and likewise represented complete 
data with respect to the variables under analysis. As data represented the entirety of each 
considered population, minimum required sample sizes were considered as met for each 
research question.  
Physician-level use of these preventive care services in the Medicare FFS 
population was aggregated to the county level, and I used Spearman’s Rank-Order 
Correlation test to determine whether physician utilization of each service correlated with 
quality score distributions (RQ1). The independent variable (IV) in each test was the 
proportion of Medicare beneficiaries that have received each service, and the dependent 
variable (DV) was the average quality score for each associated measure (i.e., receipt of 




used instead of Pearson’s correlation is because I was looking for a directional monotonic 
relationship between DV and IV, rather than a strictly linear one.  
To determine whether county-level changes in utilization trends existed from 
2012 to 2017 (RQ2), a simple linear regression was performed on the county-aggregated 
dataset with year as the IV and physician use of each preventive service as the DV. If the 
data were not normally distributed or linearly correlated, a Mann Kendall Trend Test was 
also performed to test for the presence of a monotonic trend. Finally, if changes in 
preventive care use were found at the county level over time, I looked to see whether they 
correlated with changes in associated quality measures from 2012 to 2017 (RQ3) using 
linear regression tests on annual year-over-year (YoY) changes in physician utilization of 
each preventive care service as the IV and annual YoY changes in associated quality 
scores as the DV. 
Limitations 
Several limitations existed with this study design. Physician-level medical 
expenditure data is publicly available for Medicare FFS populations, but not for MA 
distributions. In contrast, while providers tend towards adoption of single standards of 
care regardless of whether Medicare patients are FFS or managed by a health plan 
(Callison, 2016), CMS Star scores represent Medicare Advantage plans and do not 
necessarily reflect preventive care provided to Medicare FFS patients. While this study 
emphasized changes and associations within each county, differently distributed 




lack of statistical significance did not in itself indicate that no effect has occurred, just 




Chapter 4: Results  
This purpose of this study was to look at whether incentivized quality measures 
have detectably affected utilization of colonoscopies, mammograms, and influenza 
immunization at the county level. Specifically, I looked at whether county-aggregated 
differences in the use of these preventive services trended up or down between 2012 and 
2017 and whether any identified trends were correlated with affiliated quality scores. My 
research questions and hypotheses for this analysis were the following. 
RQ1: Were there county-level differences in physician utilization of preventive 
services that correlated to associated quality score distributions from 2012 to 2017?  
H01: County-level physician utilization of preventive services were not correlated 
with associated quality measure score distributions. 
Ha1: County-level physician utilization of preventive services were correlated 
with associated quality measure scores.  
RQ2: Has Medicare physician utilization of colonoscopies, mammograms, and 
influenza immunizations changed at the county level from 2012 to 2017?  
H02: Medicare physician utilization of colonoscopies, mammograms, and 
immunizations have not changed at the county level. 
Ha2: Medicare physician utilization of colonoscopies, mammograms, and 
immunizations have changed at the county level. 
RQ3: Were there observed correlations between changes in physician utilization 





H03: Changes in physician utilization of preventive care at the county-level did 
not correlate with associated quality measure score distributions. 
Ha3: Observed associations in physician utilization of preventive care at the 
county-level correlated with associated quality measure score distributions. 
Data Collection 
To conduct this analysis, Medicare Advantage plan quality score data from 2012 
to 2017 were downloaded from CMS for all contracts across the United States. Physician-
level billing data representing 100% of FFS physician services were also downloaded 
from CMS for this period, as were totals of each county’s Medicare eligible population 
and percentage enrolled in a Medicare Advantage plan for each individual year from 
2012 to 2017.  
Data Preparation 
As the unit of analysis for this study was the county, I computed weighted 
averages for counties using standard Federal Information Processing Standard (FIPS) 
codes according to the respective contribution of each plan’s membership to each county. 
The total membership of contracts reporting for BCS, CCS, and AFV, respectively, 
constituted the denominator for the weighted average calculation of each measure. All 
measures were included in the CMS Stars Quality Program for 2012 to 2017 except for 
BCS in 2015, when it was reported as a display measure. Thus, for 2015, I interpolated 
quality measure scores using both 2014 and 2016 cut points and found that the difference 




Physician-level billing for all Medicare FFS patients were aggregated using 
HCPCS codes aligned to each included quality measure (Table 2). For cancer screening, I 
included HCPCS codes for colonoscopies and mammograms utilized between 2012 and 
2017 with a “screening” designation from CMS. All HCPCS codes referencing influenza 
immunization were similarly included. 
Table 2 
 
HCPCS/CPT Codes Defining Each Preventive Measure 
Breast cancer screening Colorectal cancer screening Annual flu vaccination 
   
77057, G0202, 77063 G0121, G0105, G0120 Q2038, 90656, Q2036, 
90661, 90686, Q2037, 
Q2035, 90662, Q2039, 
90688, 90653, Q2034, 
90673, 90687, 90654, 




CMS provides a NPPES zip code for each registered physician, 99.7% of which 
directly mapped to a corresponding FIPS county code. Of these, 95.9% (n = 3013) of 
counties maintained sufficient populations from 2012 through 2017 to allow for HIPAA-
compliant reporting of Medicare-eligible populations at the county level. These excluded 
FIPS representing the least populated areas of the U.S., collectively accounting for less 
than 0.07% - 0.17% of the total national Medicare population between 2012 and 2017. 
These limitations were not found to substantively affect the analysis.    
Of the 3,143 total U.S. counties, the above mapping resulted in inclusion of 3,013 




AFVs billed to Medicare between 2012 and 2017. As indicated in Table 3, the 264,228 
unique physicians who billed Medicare for at least one of these preventive services 
between 2012 and 2017 were unevenly distributed across preventive services, with a 
greater number billing for AFV (n = 237,135) compared to physicians who billed for 
BCS (n = 41,072) or CCS (n = 26,410) over this same period. To account for variations 
in county populations, I calculated a proxy for Medicare FFS populations by subtracting 
Medicare Advantage populations from CMS-provided county totals of those who were 
Medicare eligible in December of each included year.  
As expected, physicians who billed CMS directly for an AFV sometime between 
2012 and 2017 were registered in NPPES in more counties across the 50 U.S. states 
(93.5%) compared to BCSs (50.9%) or CCSs (52.4%). Total FFS beneficiary preventive 
services ratios, as such, were intended only to assess longitudinal changes in the 
proportion of each service at the county level. 
Table 3 
 








    
Unique NPIs 41,072 26,410 237,135 
Distinct FIPS 1,601 (50.9%) 1,648 (52.4%) 2,939 (93.5%) 
 
I posed RQ1 to confirm the commonly assumed association between pooled physician 
use of preventive services and aligned quality scores using Spearman’s Rank-Order 




was explored longitudinally to determine if any observed county-level changes in 
utilization trends and quality measures existed at the county level from 2012 to 2017 
using simple linear regression and a Mann Kendall Trend Test. Finally, for RQ3 I used a 
linear regression test to determine whether YoY changes in physician utilization of each 
preventive care service correlated to changes in aligned quality scores. All statistical tests 
were performed in accordance with the planned implementation described in Chapter 3. 
Study Results 
Research Question 1 
Spearman Rank-Order Correlation tests were performed using county-level 
physician utilization of billed Medicare FFS BCSs, CCSs, and AFVs as the IV and each 
associated county-level quality score average as the DV. I analyzed data from 2012 to 
2017 to assess for a statistically significant relationship between IV and DV using SPSS 
Version 27 and derived the following outputs:  
Table 4 
 
Spearman Correlations: Breast Cancer Screen (BCS), Colorectal Cancer  
Screening (CCS), and Annual Flu Vaccination (AFV) 
 Quality Score 
Spearman's rho 
BCS utilization 
Correlation Coefficient -.018 
Sig. (2-tailed) .138 
N 6444 
CCS utilization 
Correlation Coefficient .003 
Sig. (2-tailed) .792 
N 6828 
AFV utilization 
Correlation Coefficient .073** 





**. Correlation is significant at the 0.05 level (2-tailed). 
 
These statistics represent the strength of correlation between share of Medicare eligible 
patients not enrolled in a Medicare Advantage plan within each county for whom CMS 
was directly billed for a BCS, CCS, or AFV between 2012 and 2017.  
 Higher utilization of AFV in the Medicare FFS population at the county level was 
statistically significantly associated with AFV quality scores (p < .001). However, no 
statistically significant relationship between physician utilization and aligned quality 
measure was found for either BCS (p = .138) or CCS (p = .792). Therefore, the null 
hypothesis cannot be rejected for cancer screenings: County-level physician utilization of 
BCSs and CCSs were not correlated with associated quality measure score distributions. 
For AFV, the null hypothesis was rejected: County-level physician utilization of AFV 
was correlated with the associated quality measure score at the county level from 2012 to 
2017. 
Research Question 2 
To assess whether the present Star Measure incentivization of BCS, CCS, and 
AFV has impacted county-aggregate utilization of these services over time, I performed 
separate linear regressions on these shares of physician utilization (DV) and each 
individual year, 2012 to 2017 (IV).  
Table 5 
 
Changes in Physician Utilization: Model Summaries 
Model R R Square 
Adjusted R 
Square 





BCS .069a .005 .005 .2586739 
CCS .015a .000 .000 .3438280 
AFV .052a .003 .003 .2135173 









Coefficients t Sig. 
B Std. Error Beta 
BCS 
(Constant) -20.933 3.801  -5.507 .000 
year .011 .002 .069 5.566 .000 
CCS 
(Constant) 6.061 4.908  1.235 .217 
year -.003 .002 -.015 -1.228 .220 
AFV 
(Constant) -12.754 2.079  -6.136 .000 
year .006 .001 .052 6.263 .000 
a. Dependent Variable: Medicare FFS Billing Share in County 
 
 Based on the above data, the null hypothesis was rejected for both BCS and AFV 
services: Medicare physician utilization of screening mammograms (p < .001, R2 = .005) 
and influenza immunizations (p < .001, R2 = .003) changed at the county level from 2012 
to 2017. However, no statistically significant changes in CCS were found and I failed to 
reject the null hypothesis: Medicare physician utilization of colonoscopies did not change 
at the county level from 2012 to 2017.   
 As described in my research plan, a Mann Kendall Trend Test was performed on 
CCS to test for a monotonic trend in the absence of a linear relationship. This was carried 






Mann-Kendall Trend Test / Two-tailed Test (CCS Utilization): 
Kendall's tau -0.168 
S -3909757.000 
Var(S) 35378008939.000 
p-value (Two-tailed) <0.0001 
alpha 0.050 
An approximation has been used to compute the p-value. 
 
As seen in the above output, the computed p-value of this non-parametric test is <0.0001 
so at an alpha of 0.05 the null hypothesis was rejected. Therefore, data indicate that 
colorectal cancer utilization decreased monotonically at the county-aggregate level 
between 2012 and 2017, though not linearly as was observed in both BCS and AFV. 
Research Question 3 
In RQ3, YoY changes in billed BCS, CCS, and AFV services provided by 
physicians to Medicare FFS beneficiaries were compared to aligned quality measures 
using simple linear regression in SPSS Version 27 to assess whether changes in one 
consistently correlated with changes in the other.   
Table 8 
 





Coefficients t Sig. 
B Std. Error Beta 
BCS 
(Constant) .248 .006  43.027 .000 
Utilization Delta -.001 .001 -.012 -.876 .381 
CCS 
(Constant) .133 .010  12.845 .000 





(Constant) .056 .006  9.359 .000 
Utilization Delta .000 .001 .005 .604 .546 
a. Dependent Variable: CMS Star Score Delta (YoY) 
 
For BCS, CCS, and AFV models, we fail to reject the null hypothesis. No statistically 
significant correlation was found between YoY changes in provider utilization and 
associated quality scores for BCS (p = .381), CCS (p = .601), or AFV (p = .546).  
Summary 
AFVs billed directly to Medicare statistically significantly correlated with county-
level quality score averages for the aligned AFV quality measure from 2012 to 2017. 
However, no correlations were found for county-aggregated physician billing of either 
BCSs or CCSs and their respective quality measure over this same period. Within this 
timeframe, physician utilization of BCSs and AFVs linearly trended up, and CCSs 
monotonically declined (Kendall's tau = -0.168, p < 0.0001). Changes in county-level 
utilization of BCSs, CCSs, and AFVs did not correlate with changes in associated quality 





Chapter 5: Discussion, Conclusions, and Recommendations 
The purpose of this study was to determine how preventive care incentivized by 
Medicare impacted physician utilization from 2012 to 2017, as well as clarify the 
relationship between changes in physician utilization and associated county-averaged 
quality scores. Medicare preventive care utilization is usually considered at the individual 
health plan level in accordance with the low-resolution narrative that financially 
incentivizing health plans to increase BCS, CCS, and AFV through aligned performance 
scores on CMS Star measures should improve public health.   
Consideration of population-level impact using geographic aggregations at the 
county level to analyze Medicare data from 2012 to 2017 yielded mixed results. While 
county-level physician billing of Medicare for influenza vaccinations were statistically 
significantly correlated with county-level performance on the AFV quality measure, no 
such correlation was found for BCS or CCS. Over this period, BCS and AFV linearly 
trended up while CCS monotonically trended down. However, YoY changes in county-
aggregated physician billing for BCS, CCS, and AFV preventive care were not found to 
statistically significantly correlate with respective changes in quality scores. 
Interpretation 
As described in Chapter 2, the literature on how incentivization of preventive care 
impacts physician utilization of these services emphasizes inequities across population 
segments and plan-level analyses. This study looked at population-level effects of present 
incentivization policies on preventive care at the county level. The typical unit of analysis 




incentivization intended to drive uptake of recommended cancer screenings and influenza 
immunizations within the Medicare population.  
However, when considered at the aggregated county level, only influenza 
immunizations correlated with the aligned incentivized quality measure. Changes in 
county-level utilization of BCSs, CCSs, and AFVs did not correlate with changes to 
performance on aligned quality measures between 2012 and 2017. Over this period, the 
share of each county’s Medicare-eligible population receiving an AFV was correlated 
with the associated quality score, but no such correlations were found for either BCS or 
CCS. While health plans and providers may benefit from financial incentivization of 
cancer screenings, current incentivization of preventive care services in the Medicare 
space may be insufficient to impact population health trends.  
Research Question 1 
Between 2012 and 2017, higher county percentages of Medicare populations 
receiving flu vaccinations correlated with average quality score distributions at the 
county level, but higher BCSs and CCSs did not correlate with average quality score 
performance for their aligned measures. This is reminiscent of findings by Leung, 
Beadles, Romaire, and Gulledge (2019) that preventive care measures, however sensible 
they may seem, can fail to demonstrate population improvements. As described in 
Chapter 2, research emphasizes slow payer adoption of preventive care (Pryor & Volpp, 
2018), or else focuses on disparities of utilization within a total population (Hohmann, 




findings showed that quality measure performance may not accurately reflect overall 
utilization when viewed at a population level.  
This is an important finding in that population level effect, which is the intent of 
the EBM framework upon which quality measures are built (Masic, Miokovic, & 
Muhamedagic, 2008), becomes more difficult to detect at a population level if impact is 
diluted by low utilization of a medical service. This partially explains the dearth of 
published evidence on implemented, cost-effective preventive care standards in the 
general population. However, as predicted by Matjasko, Cawley, Baker-Goering, and 
Yokum’s (2016) exposition of the behavioral economic model, the lack of public health 
effect may do little to offset payer and physician adherence to these measures. After all, 
these preventive measures are intended to help patients and not abstracted populations; 
these macro trends do not necessarily reflect an absence of either improvements to patient 
outcomes or long-term reductions in costs of care for payers focusing on quality measure 
score improvement.  
Research Question 2 
Medicare’s incentivization scheme to increase use of aligned preventive care 
slightly improved county-level utilization of BCSs and AFVs between 2012 and 2017, 
but CCSs relative to Medicare population size appeared to marginally decline. The 
reasons for this are unclear, although it could be partially explained by socioecological 
predictors of cancer screenings (Moss et al., 2019). Changes in county shares of age, sex, 




also important to note that R-Square values were very low for population level changes in 
physician billing for BCS (R2 = .005) and AFV (R2 = .003).  
CCS did not linearly change over this time, though a small declining trend was 
detected (Kandall’s tau = -0.168). The notable lack of meaningful, population-wide 
improvement in the utilization of these preventive services within Medicare populations 
is problematic. If the current approach is failing to advance meaningful use of preventive 
services, and if those services are an efficacious means by which population health could 
be improved, it would be prudent to propound a new method of incentivizing preventive 
care.  
Research Question 3 
One of the more surprising findings of my study was that, when viewed through a 
county lens, changes in physician utilization of preventive services did not correlate with 
changes in aligned quality scores from 2012 to 2017. This is somewhat counter-intuitive 
because each of the process measures under consideration are scored higher according to 
share of defined plan membership who received each service. Yet, even if health plans 
improved their scores over this period, quality score changes at an aggregate population 
level did not statistically significantly correlate with changes in physician use of each 
service. 
One factor contributing to this observation is that the rubric for each measure 
changes over time, meaning that the same performance in subsequent years can result in a 
different number of Stars being awarded. As indicated in Chapter 2, neither this nor the 




plan’s Star Scores are, in part, figured by the performance of all reporting plans in that 
category. In effect, CMS Star Measures award “the best” plans without reference to 
objective YoY improvements in preventive health measure use.  
A few examples will clarify the point. In the case of BCS, 40% compliance in 
2014 would have earned a health plan 1 Star, dropping to 39% would have earned 2 Stars 
in 2016, and if it jumped 3 percentage points to 42% in 2017 it would have been awarded 
1 Star again. Similarly, maintaining a 58% for CCS would have earned a reporting 
Medicare Advantage plan 4 Stars in 2014 and 2015, but then 2 Stars in both 2016 and 
2017. A reporting health plan consistently immunizing 68% of its membership every year 
with a flu vaccine would have received 3 Stars in 2014, 2 Stars in 2015 and 2016, and 3 
Stars again in 2017.   
While it is possible individual patients and health plans benefitted from these 
services, these moving targets are of questionable public health utility. In the absence of 
population-level changes in utilization, it is highly unlikely that aggregate impact on cost 
savings or public health outcomes presumed to result from adherence to these 
operationalized quality care efforts would be detectable. To date, no data have been 
published in the literature at the health plan level demonstrating pooled impact of 
performance variability on these quality measures and statistically significant differences 
in patient outcomes or costs. 
Discussion 
Incentivization of BCS and AFV from 2012 to 2017 may have driven increased 




county percentages of beneficiaries receiving a CCS slightly declined over this same 
period. This is consistent with Cooper, Kou, Schluchter, Dor, and Koroukian’s (2016) 
analysis of changes to preventive care utilization following the ACA. They found that 
while Medicare mammography claims increased from 2009-2010 to 2011-2012, 
colonoscopy screenings declined. Using Medicare FFS claims data, Shen et al. (2018) 
found increases in AFV use in several geographic and patient cohorts for parts of 2006-
2016 despite total estimated Medicare influenza vaccination rates remaining generally 
flat. Data altogether indicate that observed preventive care trend differences in the 
Medicare population remain sensitive to how these populations are aggregated. As my 
study results highlight, these differences contribute to discrepancies between plan-level 
and population-level impacts of incentivized quality measures. 
The finding of diminishing aggregate CCSs over this period in the Medicare space 
appears to disagree with De Moor et al.’s (2018) analysis of NHIS survey data from 2008 
to 2015, which found that coloscopies across the entire population in the U.S. from 50 to 
75 years of age increased over this period. However, this observation was inclusive of a 
much wider population, concerned with the 2008 to 2015 time frame rather than 2012 to 
2017, and included adults with both no insurance and commercial insurance in addition to 
Medicare. The decline my study observed may also be partially explained by their finding 
of statistically significantly lower coloscopy rates among those with Medicare but lacking 
private supplemental insurance, a difference that persisted even after multivariate 




At least at the county level, changes in physician utilization of BCS, CCS, and 
AFV were not found to statistically significantly correlate with quality measure 
performance on aligned measures from 2012 to 2017. This means that regardless of 
observed health plan-level changes, the overall Medicare population may not be 
detectably impacted. Changes in physician utilization of each preventive service did not 
predict any aggregate quality score impacts at the county level using this method of 
analysis. The data therefore indicate that health plan improvements over this period did 
not impact counties sufficiently to detect a statistical signal linking changes in physician 
use of these preventive measures to county-aggregated performance.  
As indicated in my literature search, the EBM applied to preventive health is 
based on the idea of benefits incurred to individuals receiving such services. The 
identified literature gap, however, pertains to the population-level impact of incentivizing 
such processes. My study found that there was no detectable correlation from 2012 to 
2017 between changes in physician billing for routine preventive care and average county 
performance scores. Health plan-specific improvements proved insufficient to drive 
population-level impact across the United States over this period. 
Limitations of the Study 
There were several limitations to this study. As described in Chapter 3, preventive 
service utilization data reflects physician-level FFS expenditures whereas plan-level 
quality scores pertain to each county’s Medicare Advantage population. I utilized 
available public data to consider county-level physician billing of preventive services in 




of each service used a calculated Medicare FFS estimate for the denominator, 
longitudinal trends could have been impacted by large shifts in Medicare beneficiary age 
and sex characteristics within each county between 2012 and 2017. 
Another limitation of this study was the method by which physicians were 
associated with counties. Public CMS data provided a primary NPPES zip code in which 
the physician was registered for each year, and I used that to group physicians into county 
aggregates. Physicians often practice in several zip codes, and this was not indicated in 
the public use file, with the greatest potential distortions identified in rural areas such as 
Alaska. Finally, physicians moving from one state to another could account for some of 
the county-specific variations in billed preventive services from 2012 to 2017, but this 
was not considered in the context of my analysis. 
Recommendations 
Future research should confirm plan-versus-geography differences in incentivized 
preventive care processes using more granular data. Effective public health policy 
requires consideration of aggregate impact, and significant literature gaps remain in 
impact metrics at any geographic aggregate level. These include demonstrated impacts in 
care efficiencies, costs, and improvements in patient outcomes associated with quality 
measures including, but not limited to, preventive care measures of BCS, CCS, and AFV.  
Adjoining research might also consider whether incentivization of these and other 
quality measures have resulted in any detectable population-aggregate use or impact. 
Expanding consideration beyond the health plan as a unit of measurement will assist in 




quality measures are process-compliance oriented activities prescribed to targeted 
population segments in the interest of lowering costs and improving patient outcomes, I 
recommend that aggregate impacts are considered in more depth. This would assist in 
aligning public health policy with effective initiatives that transcend current low-
resolution quality narratives and provide the means to attain practical, population-level 
ends.  
Implications 
This study highlights a potential discrepancy between the low-resolution narrative 
conflating increasing health plan performance on preventive care quality measures with 
physician use of those measures, and further with county-level changes in preventive care 
utilization. This may be partially explained by dilution of effect, as there may have been 
insufficient uptake of each preventive service within lower-populated areas that masked 
improvements potentially detectable only in dense urban counties. However, I found no 
indication in the present literature of any aggregated, population-level improvements to 
preventive care utilization, reduced costs of care, or improved patient outcomes at the 
state or county level.  
When analyzed at the county level, changes in physician billing of preventive 
services were not found to predict changes in associated quality measures. Overall, study 
data suggested that health plans could accurately report improvements in both physician 
utilization and quality score performance even as population-level impact remained 
undetectable. This lack of aggregate effect casts doubts upon health plans as a sufficient 




need to complement the current plan-level approach with ongoing monitoring of how 
incentivization is impacting physician behavior and population health at the geographic 
aggregate level.  
One positive social change advance of these findings is the demonstration of a 
novel method whereby plan-level data can be considered at the county level. Using this 
approach, public health officials will be able to distribute health plan quality measures to 
geographic aggregates, such as counties or Hospital Referral Regions, and analyze 
aligned data on hospitalizations, drug utilization, spending, patient outcomes, and social 
determinants of health. Analyses of socioecological predictors of changes in incentivized 
care processes and the subsequent testing of intended outcomes can also be similarly 
derived. This could help to recalibrate public health preventive care narratives and 
associated initiatives in demonstrated claims and meaningful longitudinal trends 
impacting the U.S. Medicare population. 
This study’s specific findings will also help to inform public policy reform in the 
preventive care space. Changes in average quality scores within counties do not 
necessarily reflect changes in either physician behavior or patient outcomes associated 
with that measure’s operationalization of quality. For example, aggregate declines in 
Medicare physician billing for CCSs between 2012 and 2017 at the county-level indicate 
a need to focus on improving utilization of that preventive service. Future physician-
specific analyses might yield interview cohorts of stratified providers to engender new 
thoughts around incentivization designs more likely to produce county- and population-





It is possible for health plans to demonstrate improvements in quality measure 
performance, including those measuring utilization of preventive care processes, without 
improving physician utilization at the aggregated county level. For all three preventive 
measures considered, YoY increases in BCS, CCS, and AFV quality measure scores did 
not correlate with changes in physician utilization from 2012 to 2017. A method by 
which plan-level performance in the Medicare Advantage space can be generalized to a 
geography such as a county was created and provided for future researchers.  
Incentivized preventive health quality measures have only negligibly impacted 
preventive care utilization at the county level, and changes in Medicare physician use of 
BCS, CCS, and AFV between 2012 and 2017 did not correlate with changes in aligned 
quality scores at the county level. If such preventive health service use is to meaningfully 
impact patient outcomes and reduce cost, significant changes are required to stimulate 
measurable effects at the population level and improve public health outcomes within the 






Addinsoft. (2021). XLSTAT statistical and data analysis solution. 
https://www.xlstat.com. 
Agency for Healthcare Research and Quality (AHRQ). (2020). U.S. preventive services 
task force. Department of Health & Human Services, U.S. Government. 
https://www.ahrq.gov/cpi/about/otherwebsites/uspstf/index.html  
Alharbi, A., Khan, M. M., Horner, R., Brandt, H., & Chapman, C. (2019). Impact of 
removing cost sharing under the affordable care act (ACA) on mammography and 
pap test use. BMC Public Health, 19(1), 370. https://doi.org/10.1186/s12889-019-
6665-9  
Ammi, M., & Fortier, G. (2017). The influence of welfare systems on pay-for-
performance programs for general practitioners: A critical review. Social Science 
& Medicine, 178, 157–166. https://doi.org/10.1016/j.socscimed.2017.02.019  
Benjamins, M. R., Kirby, J. B., & Bond Huie, S. A. (2004). County characteristics and 
racial and ethnic disparities in the use of preventive services. Preventive 
Medicine, 39(4), 704–712. https://doi.org/10.1016/j.ypmed.2004.02.039  
Berland, L. L., Monticciolo, D. L., Flores, E. J., Malak, S. F., Yee, J., & Dyer, D. S. 
(2019). Relationships between health care disparities and coverage policies for 
breast, colon, and lung cancer screening. Journal of the American College of 
Radiology, 16(4), 580–585. https://doi.org/10.1016/j.jacr.2018.12.025 
Bilimoria K.Y., Barnard C. (2016). The new CMS hospital quality Star Ratings: The stars 




1762. https://doi.org/10.1001/jama.2016.13679  
Callison, K. (2016). Medicare managed care spillovers and treatment intensity. Health 
Economics, 25(7), 873–887. https://doi.org/10.1002/hec.3191 
Centers for Medicare & Medicaid Services (CMS). (2019). Five-star quality rating 
system. U.S. Government. https://www.cms.gov/Medicare/Provider-Enrollment-
and-Certification/CertificationandComplianc/FSQRS  
Centers for Medicare & Medicaid Services (CMS). (2020). Healthcare effectiveness data 
and information set (HEDIS). U.S. Government. 
https://www.cms.gov/Medicare/Health-Plans/SpecialNeedsPlans/SNP-HEDIS  
Chung, S., Romanelli, R. J., Stults, C. D., & Luft, H. S. (2018). Preventive visit among 
older adults with Medicare’s introduction of Annual Wellness Visit: Closing gaps 
in underutilization. Preventive Medicine, 115, 110–118. 
https://doi.org/10.1016/j.ypmed.2018.08.018  
Cooper, G. S., Kou, T. D., Schluchter, M. D., Dor, A., & Koroukian, S. M. (2016). 
Changes in receipt of cancer screening in Medicare beneficiaries following the 
Affordable Care Act. Journal of the National Cancer Institute, 108(5), 1–8. 
https://doi.org/10.1093/jnci/djv374  
De Moor, J. S., Cohen, R. A., Shapiro, J. A., Nadel, M. R., Sabatino, S. A., Robin 
Yabroff, K., Fedewa, S., Lee, R., Paul Doria-Rose, V., Altice, C., & Klabunde, C. 
N. (2018). Colorectal cancer screening in the United States: Trends from 2008 to 





DeWalt, D. A., Berkman, N. D., Sheridan, S., Lohr, K. N., & Pignone, M. P. (2004). 
Literacy and health outcomes. Journal of General Internal Medicine, 19(12), 
1228–1239. https://doi.org/10.1111/j.1525-1497.2004.40153.x 
Eckhardt, H., Smith, P., & Quentin, W. (2019). Pay for quality: Using financial 
incentives to improve quality of care. Improving Healthcare Quality in Europe: 
Characteristics, Effectiveness and Implementation of Different Strategies. WHO 
Regional Office for Europe, pp. 357–400. 
Eijkenaar, F., Emmert, M., Scheppach, M., Schöffski, O. (2013). Effects of pay for 
performance in health care: A systematic review of systematic reviews. Health 
Policy, 110(2-3), 115–130. https://doi.org/10.1016/j.healthpol.2013.01.008 
Emanuel, E. J., Ubel, P. A., Kessler, J. B., Meyer, G., Muller, R. W., Navathe, A. S., 
Patel, P., Pearl, R., Rosenthal, M. B., Sacks, L., Sen, A. P., Sherman, P., & Volpp, 
K. G. (2016). Using behavioral economics to design physician incentives that 
deliver high-value care. Annals of Internal Medicine, 164(2), 114–119. 
https://doi.org/10.7326/M15-1330 
Florea, A., Brown, H. E., Harris, R. B., & Oren, E. (2019). Ethnic disparities in gastric 
cancer presentation and screening practice in the United States: Analysis of 1997-
2010 surveillance, epidemiology, and end results-Medicare data. Cancer 
Epidemiology, Biomarkers & Prevention, 28(4), 659–665. 
https://doi.org/10.1158/1055-9965.EPI-18-0471   
Frakt, A. B., & Jha, A. K. (2018). Face the facts: We need to change the way we do pay 





Gorges, R. J., Sanghavi, P., & Konetzka, R. T. (2019). A national examination of long-
term care setting, outcomes, and disparities among elderly dual eligibles. Health 
Affairs, 38(7), 1110–1118. https://doi.org/10.1377/hlthaff.2018.05409 
Gray, T. F., Cudjoe, J., Murphy, J., Thorpe Jr, R. J., Wenzel, J., & Han, H. R. (2017). 
Disparities in cancer screening practices among minority and underrepresented 
populations. Seminars in Oncology Nursing, 33(2), 184–198. 
https://doi.org/10.1016/j.soncn.2017.02.008 
Halamka, J. D., & Micky, T. (2017). The HITECH era in retrospect. The New England 
Journal of Medicine, 377(10), 907-909. https://doi.org/10.1056/NEJMp1709851  
Hayford, T. B., & Maeda, J. L. (2017). Issues and challenges in measuring and 
improving the quality of health care. Congressional Budget Office, U.S. 
Government. https://www.cbo.gov/system/files/115th-congress-2017-
2018/workingpaper/53387-workingpaper.pdf    
Herzer, K. R., & Pronovost, P. J. (2015). Physician motivation: Listening to what pay-
for-performance programs and quality improvement collaboratives are telling us. 
Joint Commission Journal on Quality and Patient Safety, 41(11), 522–528. 
https://doi.org/10.1016/S1553-7250(15)41069-4  
Hohmann, L. A., Hastings, T. J., Qian, J., Curran, G. M., & Westrick, S. C. (2019). 
Medicare annual wellness visits: A scoping review of current practice models and 





Houle, S. K., McAlister, F. A., Jackevicius, C. A., Chuck, A. W., & Tsuyuki, R. T. 
(2012). Does performance-based remuneration for individual health care 
practitioners affect patient care? Annals of Internal Medicine, 157(12), 889–899. 
https://doi.org/10.7326/0003-4819-157-12-201212180-00009  
Hu, J., Schreiber, M., Jordan, J., George, D. L., & Nerenz, D. (2017). Associations 
between community sociodemographics and performance in HEDIS quality 
measures: A study of 22 medical centers in a primary care network. American 
Journal of Medical Quality, 33(1), 5–13. 
https://doi.org/10.1177/1062860617695456  
Hughes, M. C., Baker, T. A., Kim, H., & Valdes, E. G. (2019). Health behaviors and 
related  disparities of insured adults with a health care provider in the United 
States, 2015–2016. Preventive Medicine, 120, 42–49. 
https://doi.org/10.1016/j.ypmed.2019.01.004  
Hughes, M. M., Saiyed, N. S., & Chen, T. S. (2018). Local-level adult influenza and 
pneumococcal vaccination disparities: Chicago, Illinois, 2015-2016. American 
Journal of Public Health, 108(4), 517–523. 
https://doi.org/10.2105/AJPH.2017.304257  
Jack L., Jr. (2018). Advancing health disparities research in population health. Preventing 
Chronic Disease, 15, E147. https://doi.org/10.5888/pcd15.180588  
Kim, H., Charlesworth, C. J., McConnell, K. J., Valentine, J. B., & Grabowski, D. C. 
(2019). Comparing care for dual-eligibles across coverage models: Empirical 





Leung, M., Beadles, C., Romaire, M., & Gulledge, M. (2019). Multi-payer advanced 
primary care practice demonstration on quality of care. American Journal of 
Managed Care, 25(9), 444–449.  
Levine, S., Malone, E., Lekiachvili, A., & Briss, P. (2019). Health care industry insights: 
Why the use of preventive services is still low. Preventing Chronic Disease, 16, 
E30. https://doi.org/10.5888/pcd16.180625  
Lohr, K.N., & Schroeder, S.A. (1990) A strategy for quality assurance in Medicare. New 
England Journal of Medicine, 322(10), 707–712.  
https://doi.org/10.1056/NEJM199003083221031  
Marshall, K., & Hale, D. (2019). The older adult and health literacy. Home Healthcare 
Now, 37(5), 292. https://doi.org/10.1097/NHH.0000000000000812  
Masic, I., Miokovic, M., & Muhamedagic, B. (2008). Evidence based medicine - new 
approaches and challenges. Acta Informatica Medica: Journal of the Society for 
Medical Informatics of Bosnia & Herzegovina, 16(4), 219–225. 
https://doi.org/10.5455/aim.2008.16.219-225  
Matanock, A., Lee, G., Gierke, R., Kobayashi, M., Leidner, A., & Pilishvili, T. (2019). 
Use of  13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal 
polysaccharide vaccine among adults aged ≥ 65 years: Updated recommendations 
of the Advisory Committee on Immunization Practices. Morbidity and Mortality 
Weekly Report, 68(46), 1069–1075. https://doi.org/10.15585/mmwr.mm6846a5  




behavioral economics to public health policy: Illustrative examples and promising 
directions. American Journal of Preventive Medicine, 50(5), S13–S19. 
https://doi.org/10.1016/j.amepre.2016.02.007  
McCalman, J., Bainbridge, R., & Bailie, R. (2019). Continuous quality improvement and 
comprehensive primary healthcare: A systems framework to improve service 
quality and health outcomes. International Journal of Integrated Care, 19(4), 436. 
https://doi.org/10.5334/ijic.s3436  
McIntyre, D., Rogers, L., & Heier, E. J. (2001). Overview, history, and objectives of 
performance measurement. Health Care Financing Review, 22(3), 7–21.   
Mendelson, A., Kondo, K., Damberg C, Low, A., Motúpuaka, M., Freeman, M., O’Neil, 
M., Relevo, R., & Kansagara, D. (2017). The effects of pay-for-performance 
programs on health, health care use, and processes of care: A systematic review. 
Annals of Internal Medicine, 166(5), 341–353. https://doi.org/10.7326/M16-1881   
Misra, A., Lloyd, J. T., Strawbridge, L. M., & Wensky, S. G. (2018). Use of Welcome to 
Medicare visits among older adults following the Affordable Care Act. American 
Journal of Preventive Medicine, 54(1), 37–43. 
https://doi.org/10.1016/j.amepre.2017.08.030  
Montminy, E. M., Karlitz, J. J., & Landreneau, S. W. (2019). Progress of colorectal 
cancer screening in United States: Past achievements and future challenges. 
Preventive Medicine, 120, 78–84. https://doi.org/10.1016/j.ypmed.2018.12.004  
Mosadeghrad A. M. (2012). A conceptual framework for quality of care. Materia Socio- 




Moss, J. L., Ehrenkranz, R., Perez, L. G., Hair, B. Y., & Julian, A. K. (2019). Geographic 
disparities in cancer screening and fatalism among a nationally representative 
sample of US adults. Journal of Epidemiology & Community Health, 73(12), 
1128–1135. https://doi.org/10.1136/jech-2019-212425  
Narayan, A. K., Elkin, E. B., Lehman, C. D., & Morris, E. A. (2018). Quantifying 
performance thresholds for recommending screening mammography: A revealed 
preference analysis of USPSTF guidelines. Breast Cancer Research and 
Treatment, 172(2), 463–468. https://doi.org/10.1007/s10549-018-4917-5  
National Committee for Quality Assurance (NCQA). (n.d.). About NCQA. 
https://www.ncqa.org/about-ncqa/  
Nowalk, M. P., Wateska, A. R., Lin, C. J., Schaffner, W., Harrison, L. H., Zimmerman, 
R. K., & Smith, K. J. (2019). Racial disparities in adult pneumococcal vaccination 
indications and pneumococcal hospitalizations. U.S. Journal of the National 
Medical Association, 111(5), 540–545. 
https://doi.org/10.1016/j.jnma.2019.04.011  
Narayan, A. K., Elkin, E. B., Lehman, C. D., & Morris, E. A. (2018). Quantifying 
performance thresholds for recommending screening mammography: A revealed 
preference analysis of USPSTF guidelines. Breast Cancer Research and 
Treatment, 172(2), 463–468. https://doi.org/10.1007/s10549-018-4917-5  
National Committee for Quality Assurance (NCQA). About NCQA: Why we’re here. 
https://www.ncqa.org/about-ncqa/contractual-services-quality-solutions-group/  






Pryor, K., & Volpp, K. (2018). Deployment of preventive interventions – time for a 
paradigm shift. New England Journal of Medicine, 378(19), 1761–1763. 
https://doi.org/10.1056/NEJMp1716272  
Richter, J. P., & Beauvais, B. (2018). Quality indicators associated with the level of 
NCQA accreditation. American Journal of Medical Quality, 33(1), 43–49. 
https://doi.org/10.1177/1062860617702963  
Roberts, E. T., Zaslavsky, A. M., & McWilliams, J. M. (2018). The value-based payment 
modifier: Program outcomes and implications for disparities. Annals of Internal 
Medicine, 168(4), 255–265. https://doi.org/10.7326/M17-1740  
Saha, S., Hoerger, T. J., Pignone, M. P., Teutsch, S. M., Helfand, M., & Mandelblatt, J. 
S. (2001). The art and science of incorporating cost effectiveness into evidence-
based recommendations for clinical preventive services. American Journal of 
Preventive Medicine, 20(3), 36–43. https://doi.org/10.1016/S0749-
3797(01)00260-4  
Schroeder, S. D. (2019). Quality focus: Continuing CMS quality innovation and 
improvement contracts. South Dakota Medicine: The Journal of the South Dakota 
State Medical Association, 72(6), 282. 
Shen, A. K., Groom, A. V., Leach, D. L., Bridges, C. B., Tsai, A. Y., & Tan, L. (2019). A 
pathway to developing and testing quality measures aimed at improving adult 





Shen, A. K., Warnock, R., Brereton, S., McKean, S., Wernecke, M., Chu, S., & Kelman, 
J. A. (2018). Influenza vaccination coverage estimates in the fee-for service 
Medicare beneficiary population 2006 - 2016: Using population-based 
administrative data to support a geographic based near real-time tool. Human 
Vaccines & Immunotherapeutics, 14(8), 1848–1852. 
https://doi.org/10.1080/21645515.2018.1462067  
Shen, A. K., Warnock, R., Selna, W., MaCurdy, T. E., Chu, S., & Kelman, J. A. (2019). 
Vaccination among Medicare-fee-for service beneficiaries: Characteristics and 
predictors of vaccine receipt, 2014–2017. Vaccine, 37(9), 1194–1201. 
https://doi.org/10.1016/j.vaccine.2019.01.010 
Simpson, V. L., & Kovich, M. (2019). Outcomes of primary care-based Medicare annual 
wellness visits with older adults: A scoping review. Geriatric Nursing, 40(6), 
590–596. https://doi.org/10.1016/j.gerinurse.2019.06.001  
Sobieski, J. (2016). The moral price of the profit motive in medicine. Honors Theses, 
Paper 952. University of Richmond Scholarship Repository. 
https://scholarship.richmond.edu  
Sung-Heui Bae. (2017). CMS nonpayment policy, quality improvement, and hospital-
acquired conditions. Journal of Nursing Care Quality, 32(1), 55–61. 
https://doi.org/10.1097/NCQ.0000000000000202  
Toseef, M. U., Jensen, G. A., & Tarraf, W. (2019). Is enrollment in a Medicaid health 




Preventive Medicine Reports, 16, 100964. 
https://doi.org/10.1016/j.pmedr.2019.100964 
Valuck, T. B., Sampsel, S., Sloan, D. M., & Van Meter, J. (2019). Improving quality 
measure maintenance: Navigating the complexities of evolving 
evidence. American Journal of Managed Care, 25(6), e188–e191. 
Wilson, B. J., Bell, N. R., Grad, R., Thériault, G., Dickinson, J. A., Singh, H., Groulx, S., 
& Szafran, O. (2018). Practice organization for preventive screening. Canadian 
Family Physician, 64(11), 816–820.  
Xu, W. Y., Wickizer, T. M., & Jung, J. K. (2019). Effectiveness of Medicare cost-sharing 
elimination for cancer screening on utilization. BMC Health Services Research, 
19, 392. https://doi.org/10.1186/s12913-019-4135-9  
Young, R. A., Roberts, R. G., & Holden, R. J. (2017). The challenges of measuring, 
improving, and reporting quality in primary care. Annals of Family Medicine, 
15(2), 175–182. https://doi.org/10.1370/afm.2014 
